This website uses cookies to enhance the user experience.
PR

Preben René Hjallum1970

Shareholdings
2
14
Norway Business roles
16

Roles

Boards

NameRoleTotal operating incomeTotal equityShares
P
PRESTEGÅRDEN KRAGERØ AS
Contact Person
1,262,183
1,233,715
50 %
indirectly
H
HJALLUM EIENDOM 1 AS
Contact Person
796,687
1,250,863
50 %
indirectly
H
HJALLUM HOLDING AS
Chairman
-
5,540,151
50 %
directly
P
PYNT AS
Chairman
1,014,698
691,529
50 %
directly
Chairman
1,280,151
1,353,921
16.67 %
indirectly
P
PLASTINOR AS
Chairman
2,332,791
486,018
12.5 %
indirectly
M
MEDEVICE AS
Chairman
-
-512,638
10 %
indirectly
M
MARINEX AS
Board Member
2,806,325
-742,804
10 %
indirectly
P
PAVELS INNOVATION AS
Board Member
10,278,238
5,795,961
7.08 %
indirectly
K
KAASS DISCOVERY AS
Board Member
2,129,281
10,435,740
2.28 %
indirectly
S
STILY AS
Chairman
29,936
219,357
1.75 %
indirectly
Board Member
-
126,675,696
1.22 %
indirectly
P
PALLA PHARMA EIENDOM AS
Board Member
-
24,430
1.22 %
indirectly
Board Member
5,315,783
1,836,893
-
Last update: May 23, 2024

Shares owned by Preben René Hjallum

NameShare classTotal operating incomeTotal equityShare
H
HJALLUM HOLDING AS
Ordinære aksjer
0
5,540,151
50 %
directly
P
PYNT AS
Ordinære aksjer
1,014,698
691,529
50 %
directly
P
PRESTEGÅRDEN KRAGERØ AS
1,262,183
1,233,715
50 %
indirectly
H
HJALLUM EIENDOM 1 AS
796,687
1,250,863
50 %
indirectly
1,280,151
1,353,921
16.67 %
indirectly
P
PLASTINOR AS
2,332,791
486,018
12.5 %
indirectly
M
MEDEVICE AS
0
-512,638
10 %
indirectly
M
MARINEX AS
2,806,325
-742,804
10 %
indirectly
P
PAVELS INNOVATION AS
10,278,238
5,795,961
7.08 %
indirectly
P
PROTOFAB AS
1,305,926
273,153
3.18 %
indirectly
K
KAASS DISCOVERY AS
2,129,281
10,435,740
2.28 %
indirectly
S
STILY AS
29,936
219,357
1.75 %
indirectly
0
126,675,696
1.22 %
indirectly
P
PALLA PHARMA NORWAY AS
213,177,159
52,608,967
1.22 %
indirectly
P
PALLA PHARMA EIENDOM AS
0
24,430
1.22 %
indirectly
F
FUNKY GARDEN AS
0
-1,259,229
0.71 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025